Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00507754 · ClinicalTrials.gov registry record
Latent Tuberculosis Infection in Cancer Patients
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 24
- Enrollment target
NCT00507754: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00507754 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00507754 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
Primary Objective: 1\. To evaluate the performance of the new T-SPOT.TB test and the conventional TST for screening of Latent Tuberculosis infections in patients with cancer and those undergoing Hematopoietic Stem Cell Transplant. Secondary Objectives: 1. To examine the factors associated with positive response to T-SPOT.TB and the TST (tuberculin skin test) in patients with anergy. 2. To determine the impact of immunosuppressive and antineoplastic therapy on the screening performance of T-SPOT.TB and the TST in cancer patients.
Interventions
- OTHER T-SPOT TB test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2007-06 |
| Est. Completion | 2011-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00507754
The ClinicalTrials.gov registry entry for NCT00507754 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which T-SPOT TB test is the first listed.
NCT00507754 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00507754 about?
NCT00507754 is a clinical study titled "Latent Tuberculosis Infection in Cancer Patients". Primary Objective: 1\. To evaluate the performance of the new T-SPOT.TB test and the conventional TST for screening of Latent Tuberculosis infections in patients with cancer and those undergoing Hematopoietic Stem Cell Transplant. Secondary Objectives: 1. To examine the factors associated with po...
What is the current status of trial NCT00507754?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2007-06. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00507754?
The interventions under investigation include: T-SPOT TB test (OTHER).
Who is sponsoring clinical trial NCT00507754?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.